Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;3(3):e172.
doi: 10.1016/S2665-9913(21)00031-X. Epub 2021 Jan 27.

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?

Affiliations

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?

Luis Ayerbe et al. Lancet Rheumatol. 2021 Mar.
No abstract available

PubMed Disclaimer

References

    1. Rentsch CT, DeVito NJ, MacKenna B, et al. Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. Lancet Rheumatol. 2021;3:e19–e27. - PMC - PubMed
    1. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. - PMC - PubMed
    1. Fiolet T, Guihur A, Rebeaud M, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:19–27. - PMC - PubMed
    1. Di Castelnuovo A, Costanzo S, Cassone A, Cauda R, de Gaetano G, Iacoviello L. Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients. medRxiv. 2020 doi: 10.1101/2020.11.01.20223958. published online Nov 4. (preprint) - DOI

LinkOut - more resources